Research Update: State of Rio de Janeiro 'BBB-' Ratings Affirmed, Outlook Stable On Sound Fiscal Management Jul 12

  • ID: 2163288
  • July 2012
  • Standard & Poors
1 of 3


  • Rio de Janeiro (State of)
  • MORE

The strengthening in the administration and the national Fiscal Responsibility Law are expected to sustain the state of Rio de Janeiro's sound fiscal performance during the next three years despite an ambitious investment plan. Debt levels will remain above 100% of revenues; however, low fiscal deficits are expected. We are affirming our 'BBB-' global scale and 'brAAA' national scale ratings on the state of Rio de Janeiro. The stable outlook reflects the state's growing ability to maintain its increasing public investment program. On July 2, 2012, Standard & Poor's Ratings Services affirmed its 'BBB-' global scale and 'brAAA' national scale issuer credit ratings on the State of Rio de Janeiro (SRJ). The outlook on these ratings remains stable. The strong...

Companies mentioned in this report are: Rio de Janeiro (State of)
Action: Affirmed

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Product Type: Research Update
Research updates complement media releases. They offer more depth and detail than summary analyses by incorporating all information published in the media release. They are more up to date than summaries in that they are published simultaneously with media releases.

Note: Product cover images may vary from those shown
2 of 3

Rio de Janeiro (State of)

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.